DK3675894T3 - Sammensætning til kontrolleret ovariestimulation - Google Patents

Sammensætning til kontrolleret ovariestimulation Download PDF

Info

Publication number
DK3675894T3
DK3675894T3 DK18768795.9T DK18768795T DK3675894T3 DK 3675894 T3 DK3675894 T3 DK 3675894T3 DK 18768795 T DK18768795 T DK 18768795T DK 3675894 T3 DK3675894 T3 DK 3675894T3
Authority
DK
Denmark
Prior art keywords
ovarium
stimulation
composition
controlled
ovarium stimulation
Prior art date
Application number
DK18768795.9T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3675894T3 publication Critical patent/DK3675894T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18768795.9T 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation DK3675894T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17189119 2017-09-01
PCT/EP2018/073442 WO2019043143A1 (en) 2017-09-01 2018-08-31 COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

Publications (1)

Publication Number Publication Date
DK3675894T3 true DK3675894T3 (da) 2022-01-24

Family

ID=59772482

Family Applications (2)

Application Number Title Priority Date Filing Date
DK21196378.0T DK3973982T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation
DK18768795.9T DK3675894T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK21196378.0T DK3973982T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation

Country Status (32)

Country Link
US (2) US11744879B2 (da)
EP (3) EP3973982B1 (da)
JP (2) JP6856819B2 (da)
KR (2) KR20200045543A (da)
CN (2) CN111050787A (da)
AR (1) AR112541A1 (da)
AU (1) AU2018326556B2 (da)
BR (1) BR112020003379A2 (da)
CA (1) CA3073624A1 (da)
CL (1) CL2020000482A1 (da)
DK (2) DK3973982T3 (da)
EA (1) EA202090480A1 (da)
ES (2) ES2904787T3 (da)
FI (1) FI3973982T3 (da)
HR (2) HRP20241171T1 (da)
HU (2) HUE056726T2 (da)
IL (1) IL272763B2 (da)
JO (1) JOP20200034B1 (da)
LT (2) LT3973982T (da)
MA (2) MA50034B1 (da)
MD (2) MD3675894T2 (da)
MX (2) MX2020002235A (da)
MY (1) MY200791A (da)
PH (1) PH12020500404A1 (da)
PL (2) PL3973982T3 (da)
PT (2) PT3973982T (da)
RS (2) RS65945B1 (da)
SG (1) SG11202003840QA (da)
SI (2) SI3973982T1 (da)
TW (1) TWI749255B (da)
UA (1) UA126869C2 (da)
WO (1) WO2019043143A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3973982T1 (sl) 2017-09-01 2024-10-30 Ferring B. V. Sestavek za nadzorovano stimulacijo jajčnikov
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250148B2 (en) * 2000-01-27 2008-07-02 Laboratoires Serono SA Use of fsh for treating infertility
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2494928T3 (es) * 2007-09-21 2014-09-16 Pharmabrand S.A. Composición que comprende polisacáridos mucilaginosos derivados de Aloe barbadensis combinados con liposomas, procedimiento para la obtención de los mismos y su uso como protector solar, un agente antiacné, un regenerador epidérmico y un hidratante
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
WO2011089602A2 (en) * 2010-01-21 2011-07-28 Ramot At Tel-Aviv University Ltd. Aloe-emodin derivatives and use thereof for the treatment of cancer
US9320778B2 (en) 2010-09-29 2016-04-26 Ferring B.V. Method for controlled ovarian stimulation with combined FSH and hCG
WO2012168680A1 (en) 2011-06-06 2012-12-13 Ferring B.V. Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
AR100132A1 (es) 2014-04-18 2016-09-14 Glycotope Gmbh Un método para hiperestimulación ovárica controlada para estimular el desarrollo de múltiples folículos ováricos en un sujeto femenino
EP3261661B1 (en) 2015-02-26 2023-10-18 Ferring B.V. Menotropin for treating infertility
HUE054300T2 (hu) 2015-04-17 2021-08-30 Ferring Bv FSH-t tartalmazó, meddõség kezelésére szolgáló készítmény
RS61163B1 (sr) 2015-04-24 2021-01-29 Ferring Bv Postupak proizvodnje gonadotrofina
US10906953B2 (en) 2015-06-26 2021-02-02 Ferring B.V. Methods of purification and/or viral inactivation
SI3973982T1 (sl) 2017-09-01 2024-10-30 Ferring B. V. Sestavek za nadzorovano stimulacijo jajčnikov
WO2019211153A1 (en) 2018-04-30 2019-11-07 Ferring B.V. Composition for controlled ovarian stimulation
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Also Published As

Publication number Publication date
AR112541A1 (es) 2019-11-06
EP3973982A1 (en) 2022-03-30
PT3675894T (pt) 2022-01-25
US20240024424A1 (en) 2024-01-25
BR112020003379A2 (pt) 2020-08-25
JP7373479B2 (ja) 2023-11-02
US20200197493A1 (en) 2020-06-25
AU2018326556B2 (en) 2024-09-26
HUE056726T2 (hu) 2022-03-28
PT3973982T (pt) 2024-09-16
JOP20200034A1 (ar) 2020-02-13
US12653864B2 (en) 2026-06-16
HUE068024T2 (hu) 2024-12-28
UA126869C2 (uk) 2023-02-15
JOP20200034B1 (ar) 2024-04-18
EP3973982B1 (en) 2024-07-31
SG11202003840QA (en) 2020-05-28
HRP20211802T1 (hr) 2022-03-04
IL272763B1 (en) 2023-10-01
IL272763B2 (en) 2024-02-01
ES2904787T3 (es) 2022-04-06
EP3675894A1 (en) 2020-07-08
MD3675894T2 (ro) 2022-03-31
MA56224B1 (fr) 2024-09-30
FI3973982T3 (fi) 2024-09-23
JP2021046398A (ja) 2021-03-25
LT3973982T (lt) 2024-09-10
CL2020000482A1 (es) 2020-06-26
MA50034A (fr) 2021-05-12
CN111050787A (zh) 2020-04-21
ES2989511T3 (es) 2024-11-26
RS62810B1 (sr) 2022-02-28
WO2019043143A1 (en) 2019-03-07
KR20250078595A (ko) 2025-06-02
EP4427806A2 (en) 2024-09-11
LT3675894T (lt) 2021-12-10
PL3675894T3 (pl) 2022-02-21
PL3973982T3 (pl) 2024-11-04
MA56224A (fr) 2022-04-20
SI3675894T1 (sl) 2022-01-31
CN120617484A (zh) 2025-09-12
SI3973982T1 (sl) 2024-10-30
EP4427806A3 (en) 2024-10-09
IL272763A (en) 2020-04-30
MA50034B1 (fr) 2022-02-28
RS65945B1 (sr) 2024-10-31
JP6856819B2 (ja) 2021-04-14
EA202090480A1 (ru) 2020-07-20
MX2024009224A (es) 2024-08-06
TW201919687A (zh) 2019-06-01
HRP20241171T1 (hr) 2024-11-22
TWI749255B (zh) 2021-12-11
MD3973982T2 (ro) 2024-11-30
US11744879B2 (en) 2023-09-05
MX2020002235A (es) 2020-07-20
AU2018326556A1 (en) 2020-03-05
JP2020528071A (ja) 2020-09-17
CA3073624A1 (en) 2019-03-07
EP3675894B1 (en) 2021-11-03
PH12020500404A1 (en) 2021-03-01
KR20200045543A (ko) 2020-05-04
DK3973982T3 (da) 2024-09-23
MY200791A (en) 2024-01-16

Similar Documents

Publication Publication Date Title
EP3722358A4 (en) COMPOSITION
DK3697376T3 (da) Sammensætning
EP3493800A4 (en) CANNABIS
DK3594238T3 (da) Antistofsammensætninger til tumorbehandling
EP3514627A4 (en) PHOTO POLYMER COMPOSITION
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3528902T3 (da) Ringegelsammensætning
DK3787667T3 (da) Sammensætning til kontrolleret ovariestimulation
EP3812426A4 (en) CURABLE COMPOSITION
EP3590546A4 (en) COMPOSITION FOR SKIN INJECTION
EP3480228A4 (en) COMPOSITION
EP3530711A4 (en) GEL COMPOSITION
EP3556804A4 (en) COMPOSITION
EP3443034C0 (en) COMPOSITION
EP3675653C0 (fr) Composition antimycotoxine
EP3524627A4 (en) COMPOSITION
IL272763A (en) The composition for controlled stimulation of the ovary
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
EP3521505A4 (en) COMPOSITION
PL3481406T3 (pl) Kompozycja
DK3349752T3 (da) Aza-adamantan sammensætning til sårheling
KR20180085014A (ko) 펩티드 조성물
EP3782632A4 (en) ANTISTRESS COMPOSITION
ES1209313Y (es) Composicion liofilizada
DK3294682T3 (da) Sammensætning til overfladebehandling